If you're a woman on hormone therapy right now, whether that's a patch, a gel, a cream, or a pill, there's a very good chance you're only taking one estrogen. Your body made three: estrone, estradiol, and estriol. And here's the part nobody tells you. There has never been a study showing that replacing just one of them is enough. I broke this whole thing down in this episode of The Trusted Pharmacist, and I want to walk you through it here too.
A while back, a physician with a large following made a video about this exact topic. Her message was that this is settled, estradiol is enough, and people like me should stop confusing women. She brought a citation list, which I genuinely respect. So I read every one of them.
One of her strongest studies, cited as proof that estradiol reduces inflammation, used a hormone preparation that was eighty percent estriol, plus progesterone, DHEA, and testosterone. She cited an estriol study to argue against estriol. Another paper said right in its own limitations section that the authors couldn't separate estradiol's effect from a second drug the patients were taking. If the people declaring this conversation over haven't read their own evidence, the conversation is not over.
Why Estriol Disappeared (It's Not What You Think)
Nobody studied estriol and found it useless. The real answer is more boring than that, and honestly much worse.
Estriol is a molecule your body already makes, which means nobody can patent it. And if you can't patent it, no pharmaceutical company is going to spend the roughly $200 million it takes to run trials and bring it to market, because at the end of that process anybody could make it.
That one fact just cascades. No product means no sales rep in the waiting room. No sales rep means it doesn't come up at the continuing education dinner, or the residency lecture, and barely in pharmacy school. I went to pharmacy school. I can tell you exactly how much time we spent on estriol. Almost none.
Because it never enters the training pipeline, it never enters the guidelines. So a careful, conscientious physician who did everything right will never prescribe it. Not because she looked at it and rejected it. Because she never encountered it in the first place. Estriol lost a business argument, and we mistook the silence for a verdict.
One thing you should know about me before we go further: I own a compounding pharmacy, and we make Bi-Est, the combination of estriol and estradiol. That's how I make a living, and you should weigh that against everything I say here. I honestly don't care where you fill your prescription. I'm making this argument because women deserve the full conversation, and I've been making it for twenty years.
What You Actually Need to Know
Alpha builds, beta protects
Your body has two main nuclear estrogen receptors, alpha and beta, and they frequently do opposite things. Receptor alpha drives growth. It's the receptor behind what hormone therapy is famous for, like controlling hot flashes and maintaining bone density, along with supporting the heart. Those are real benefits, and I'm not here to talk you out of estradiol.
Receptor beta tends to do the opposite. It restrains growth and quiets inflammation, and it shows up heavily in your brain, your gut lining, your immune cells, and your urogenital tissue. You need both, and they are not interchangeable.
Binding is not activation
The most common pushback I get goes like this: estradiol binds both receptors, so you're covered. Here's the sentence I want you to take away. Binding is not activation. A key that fits the lock is not the same as a key that turns it.
When researchers measured actual gene activity, not just binding, estradiol produced about one fifth of the output at receptor beta that it produced at receptor alpha. Same molecule, same concentration, a fraction of the effect. And the structure of the receptor explains why. Beta is missing part of the machinery alpha uses to fully switch on, and crystal structure work showed estradiol can actually push beta's switch into the off position while it's sitting there.
If your cholesterol runs high, it gets worse. Your body makes more of a byproduct called 27-hydroxycholesterol, and it interferes with estradiol's signaling at receptor beta specifically. So the women who need beta support the most, women with metabolic syndrome or extra weight around the middle, have their own physiology working against a receptor their prescription already reaches poorly.
Estriol is the specialist
Estriol is a weaker estrogen overall. That's true, and it's a feature, not a bug. What matters isn't how strong it is. It's where it leans. In the most complete binding study we have, which mapped 74 estrogen metabolites against both receptors, estriol showed a 10 to 18 fold preference for receptor beta. Estradiol is the master key that fits alpha perfectly and beta poorly. Estriol goes where estradiol underperforms.
Where the gap shows up in real life
Deep in your brainstem is the dorsal raphe nucleus, where most of your serotonin is made, and it runs almost exclusively on receptor beta. In animal work modeling late menopause, estradiol had lost its antidepressant effect almost entirely, but a beta-selective compound still worked. The hippocampus, the seat of your memory, showed the same pattern. The beta compound improved memory performance and the alpha compound did not.
Your entire GI tract is dominated by receptor beta, which maintains the tight junctions in your gut wall. When that signaling drops, those seals loosen and permeability increases. That's a receptor-level mechanism behind what people call leaky gut, not a wellness slogan. And in a colon tissue experiment that ran three arms side by side, estradiol at replacement-range concentrations didn't reduce cell proliferation. Only the beta-selective compound did.
Then there's the immune system. A prospective study gave postmenopausal women estradiol for fourteen to seventeen weeks and measured their immune systems comprehensively. Not one marker changed. Meanwhile, vaginal estriol has been used for decades, and a landmark New England Journal of Medicine study found it cut recurrent UTIs from about six a year to about half an infection a year. Nobody calls that fringe. It's in the urology guidelines. So why did we decide estriol's usefulness stops at the vaginal wall?
The human evidence people say doesn't exist
A neurologist at UCLA noticed something clinicians had seen for decades. Women with multiple sclerosis often improve dramatically during pregnancy, when estriol rises about a thousandfold. So she gave oral estriol to ten women with relapsing-remitting MS. Inflammatory brain lesions dropped by more than 70 percent. She stopped the estriol and the lesions came back. She restarted it and they went down again. On, off, on. That's about as close as clinical medicine gets to proving causation.
Then came a phase two randomized placebo-controlled trial. 164 women across 16 sites, relapse rates cut by roughly a third to a half. And notice who funded it. The NIH and the National MS Society, not a drug company. Give women estradiol and the immune system doesn't move. Give women estriol and it moves, reverses when you stop, and comes back when you restart.
Your Homework Before Your Next Appointment
Start with the bottle, the box, or the pharmacy label. Which estrogens are actually listed? I'd bet most women reading this have never once checked, and it takes thirty seconds.
Now, if estradiol alone has you feeling like yourself again, don't touch a thing. That's a win, and this episode was never an argument against your therapy.
But if something's still off, the mood, the sleep, the gut, the brain fog, bring two questions to your next visit. Is my therapy reaching both estrogen receptors, or just one? And has estriol been considered for me? If you hear "it's not FDA approved," that's true, and now you know the backstory. Ask whether that's a science problem or a regulatory one, because in Europe, estriol is prescribed routinely.
And one detail that trips up more women than almost anything else: if you're on a cream, your labs need to be drawn two to four hours after you apply it. Draw at the wrong time and the level looks low even when the therapy is absorbing just fine. I've watched women lose a working therapy over nothing more than a badly timed blood draw.
Don't take my word for any of this, either. The research referenced in this episode can be found on my blog, with every study listed by author, journal, year, and PubMed ID. Pull them yourself.
Where to Take Your Questions Next
I told you to start with your prescription label. Fair warning: once you look, you're going to have questions. And finding somewhere to actually ask them is harder than it should be.
A fifteen-minute appointment doesn't leave room for "wait, explain that to me." And searching online just hands you fifty answers that all disagree with each other.
The Magnolia Inner Circle is where those questions finally have somewhere to go.
You bring what you're confused about, and pharmacists who read this research every day walk you through it in plain language. Over time, you stop needing someone to interpret everything for you, because you start understanding how your own body works.
Inside you'll also get challenges, deeper trainings, supplement discounts, a community asking the same questions you are, and resources that turn all that noise into an actual plan.